Skip to main content

PROFUND ADVISORS LLC

Position in APLS — Apellis Pharmaceuticals, Inc.

CIK 1129919 BETHESDA, MD

Position in APLS

as of Mar 31, 2026 · filed Apr 27, 2026
Position Value
$0
+$0 QoQ
Shares Held
81,190
+31.3% QoQ
Ownership
0.063%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in APLS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PROFUND ADVISORS LLC holds $162,985,629 across 169 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in APLS

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-03-31 81,190
2025-12-31 61,832
2025-09-30 34,712
2025-06-30 28,676
2025-03-31 35,657
2024-12-31 44,319
2024-09-30 38,614
2024-06-30 42,968
2024-03-31 22,533
2023-12-31 22,558
2023-09-30 35,153
2023-06-30 16,387
2023-03-31 21,694
2022-12-31 12,722
2022-09-30 12,407